Attacker Value
Unknown
(0 users assessed)
Exploitability
Unknown
(0 users assessed)
User Interaction
Unknown
Privileges Required
Unknown
Attack Vector
Unknown
0

CVE-2011-3386

Disclosure Date: September 02, 2011
Add MITRE ATT&CK tactics and techniques that apply to this CVE.

Description

Unspecified vulnerability in Medtronic Paradigm wireless insulin pump 512, 522, 712, and 722 allows remote attackers to modify the delivery of an insulin bolus dose and cause a denial of service (adverse human health effects) via unspecified vectors involving wireless communications and knowledge of the device’s serial number, as demonstrated by Jerome Radcliffe at the Black Hat USA conference in August 2011. NOTE: the vendor has disputed the severity of this issue, saying “we believe the risk of deliberate, malicious, or unauthorized manipulation of medical devices is extremely low… we strongly believe it would be extremely difficult for a third-party to wirelessly tamper with your insulin pump… you would be able to detect tones on the insulin pump that weren’t intentionally programmed and could intervene accordingly.”

Add Assessment

No one has assessed this topic. Be the first to add your voice to the community.

CVSS V3 Severity and Metrics
Base Score:
None
Impact Score:
Unknown
Exploitability Score:
Unknown
Vector:
Unknown
Attack Vector (AV):
Unknown
Attack Complexity (AC):
Unknown
Privileges Required (PR):
Unknown
User Interaction (UI):
Unknown
Scope (S):
Unknown
Confidentiality (C):
Unknown
Integrity (I):
Unknown
Availability (A):
Unknown

General Information

Technical Analysis